Retail & Wholesale » Retail | JW Holdings Corp.

JW Holdings Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
16,164
5,090
966
17,534
56,870
36,439
Depreciation, Depletion & Amortization
25,405
20,270
21,718
22,226
32,026
34,962
Other Funds
20,279
42,156
1,932
36,968
-
98,796
Funds from Operations
33,850
8,579
43,737
39,110
77,339
170,197
Changes in Working Capital
87,880
25,755
68,439
69,962
67,721
25,565
Net Operating Cash Flow
54,030
17,176
24,701
30,852
9,619
195,762
Capital Expenditures
15,719
16,409
12,871
14,991
25,668
Sale of Fixed Assets & Businesses
730
123
44
326
329
Purchase/Sale of Investments
81,958
22,751
28,101
35,998
39,064
Net Investing Cash Flow
41,565
1,901
39,285
55,537
11,427
Cash Dividends Paid - Total
3,939
1,273
1,336
2,534
9,259
Issuance/Reduction of Debt, Net
39,583
25,508
58,363
22,778
22,309
Net Financing Cash Flow
15,293
21,211
64,924
125,002
29,458
Net Change in Cash
2,340
2,281
1,403
37,881
11,596
Free Cash Flow
61,048
24,001
32,361
41,574
7,688
Net Assets from Acquisitions
-
-
1,043
4,510
3,192
Other Sources
5,896
23,725
2,691
2,245
3,817
Change in Capital Stock
72
5,835
9,829
67,789
2,110
Exchange Rate Effect
489
147
465
731
3,184
Other Uses
31,300
32,090
4
2,609
2,922

About JW Holdings

View Profile
Address
JW Tower
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-holdings.co.kr
Updated 07/08/2019
JW Holdings Corp. engages in the manufacture and sale of medicines and medical supplies. Its major products include transfusion fluids, medical appliances such as digital X-rays, light-emitting diode (LED) astral lamps, incubators and others. It exports antimicrobials, antifungal agents, anticancer agents, gastrointestinal agents, basic I.